Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 237,200 | 143,900 | 291,500 | 202,100 | 132,900 |
| Depreciation Amortization | 28,800 | 14,100 | 53,700 | 42,200 | 27,800 |
| Income taxes - deferred | 700 | 200 | -26,400 | 1,100 | 1,300 |
| Accounts receivable | -8,700 | 5,400 | -26,500 | -4,000 | -22,200 |
| Other Working Capital | -3,000 | -6,800 | 54,500 | 2,300 | -29,200 |
| Other Operating Activity | -25,800 | -55,700 | 15,300 | 3,700 | 5,500 |
| Operating Cash Flow | $229,200 | $101,100 | $362,100 | $247,400 | $116,100 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,700 | 52,400 | 69,100 | -38,200 | 69,200 |
| PPE Investments | -66,300 | -36,800 | -106,000 | -62,300 | -39,200 |
| Net Acquisitions | N/A | N/A | -36,600 | N/A | N/A |
| Purchase Of Investment | N/A | -1,500 | -2,000 | 400 | 0 |
| Sale Of Investment | -1,600 | N/A | 2,800 | N/A | 1,800 |
| Purchase Sale Intangibles | N/A | N/A | -7,000 | -7,000 | -7,000 |
| Other Investing Activity | -100 | -400 | -6,100 | -6,100 | -6,100 |
| Investing Cash Flow | $-59,300 | $13,700 | $-78,800 | $-106,200 | $25,700 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 332,200 | 163,800 | 407,000 | 237,900 | 205,100 |
| Debt Repayment | -292,000 | -158,300 | -367,500 | -211,600 | -169,000 |
| Common Stock Issued | 27,400 | 13,800 | 100,100 | 89,400 | 64,400 |
| Common Stock Repurchased | -246,600 | -107,700 | -344,100 | -166,300 | -143,200 |
| Other Financing Activity | 64,800 | 63,500 | 48,900 | 41,900 | 34,500 |
| Financing Cash Flow | $-114,200 | $-24,900 | $-155,600 | $-8,700 | $-8,200 |
| Exchange Rate Effect | 6,100 | 700 | 12,000 | 2,100 | -500 |
| Beginning Cash Position | 310,900 | 310,900 | 171,200 | 171,200 | 171,200 |
| End Cash Position | 372,700 | 401,500 | 310,900 | 305,800 | 304,300 |
| Net Cash Flow | $61,800 | $90,600 | $139,700 | $134,600 | $133,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 229,200 | 101,100 | 362,100 | 247,400 | 116,100 |
| Capital Expenditure | -66,300 | -36,800 | -109,000 | -64,900 | -39,200 |
| Free Cash Flow | 162,900 | 64,300 | 253,100 | 182,500 | 76,900 |